Literature DB >> 3105060

Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.

B R Seizinger, G Rouleau, L J Ozelius, A H Lane, P St George-Hyslop, S Huson, J F Gusella, R L Martuza.   

Abstract

Bilateral acoustic neurofibromatosis (BANF) is a genetic defect associated with multiple tumors of neural crest origin. Specific loss of alleles from chromosome 22 was detected with polymorphic DNA markers in two acoustic neuromas, two neurofibromas, and one meningioma from BANF patients. This indicates a common pathogenetic mechanism for all three tumor types. The two neurofibromas were among three taken from the same patient, and both showed loss of identical alleles demonstrating that the same chromosome suffered deletion in both tumors. The third neurofibroma from this patient showed no detectable loss of heterozygosity, which suggests the possibility of a more subtle mutational event that affects chromosome 22. In the two acoustic neuromas, only a portion of chromosome 22 was deleted, narrowing the possible chromosomal location of the gene that causes BANF to the region distal to the D22S9 locus in band 22q11. The identification of progressively smaller deletions on chromosome 22 in these tumor types may well provide a means to clone and characterize the defect.

Entities:  

Mesh:

Year:  1987        PMID: 3105060     DOI: 10.1126/science.3105060

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  47 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

3.  The neurosurgical aspects of neurofibromatosis 2: diagnosis and management.

Authors:  M Turgut; S Palaoğlu; O E Ozcan
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

4.  Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.

Authors:  G A Rouleau; B R Seizinger; W Wertelecki; J L Haines; D W Superneau; R L Martuza; J F Gusella
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

5.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

Authors:  A B Bianchi; S I Mitsunaga; J Q Cheng; W M Klein; S C Jhanwar; B Seizinger; N Kley; A J Klein-Szanto; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Zhi-Hai Peng; Fang Zhang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Pleomorphic xanthoastrocytoma associated with von Recklinghausen neurofibromatosis.

Authors:  M M Ozek; A Sav; M N Pamir; A F Ozer; E Ozek; C Erzen
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

8.  Maternal and perinatal risk factors for childhood brain tumors (Sweden).

Authors:  M S Linet; G Gridley; S Cnattingius; H S Nicholson; U Martinsson; B Glimelius; H O Adami; M Zack
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

Review 9.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

Review 10.  Genes associated with tumor suppression and growth control in the human nervous system.

Authors:  B R Seizinger
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.